Bogart Wealth LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.4K Sell
373
-82,616
-100% -$6.61M ﹤0.01% 680
2025
Q4
$7.91M Buy
82,989
+15,427
+23% +$1.51M 0.32% 71
2025
Q3
$6.6M Buy
67,562
+1,571
+2% +$163K 0.27% 88
2025
Q2
$7.09M Buy
65,991
+3,070
+5% +$311K 0.3% 83
2025
Q1
$6.35M Buy
62,921
+62,819
+61,587% +$6.33M 0.3% 80
2024
Q4
$9.11K Buy
102
+11
+12% +$968 ﹤0.01% 763
2024
Q3
$7.63K Hold
91
﹤0.01% 749
2024
Q2
$7.01K Buy
91
+10
+12% +$732 ﹤0.01% 720
2024
Q1
$5.55K Buy
81
+20
+33% +$1.29K ﹤0.01% 747
2023
Q4
$3.53K Hold
61
﹤0.01% 816
2023
Q3
$3.22K Hold
61
﹤0.01% 814
2023
Q2
$3.3K Hold
61
﹤0.01% 803
2023
Q1
$3.05K Buy
+61
New +$2.88K ﹤0.01% 832
2022
Q4
Sell
-242
Closed -$9K 1074
2022
Q3
$9K Buy
+242
New +$9.71K ﹤0.01% 558

Other funds holding BSX

Bogart Wealth LLC's BSX Position: Q1 2026 in Review

Bogart Wealth LLC reduced its Boston Scientific (BSX) stake by 100% in Q1 2026, selling an estimated $6.61M and leaving 373 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Bogart Wealth LLC first reported a position in BSX in Q3 2022 and has held it in 14 quarters since. The position peaked at $7.91M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Bogart Wealth LLC held 373 shares of Boston Scientific worth $23.4K as of Q1 2026.
  • Bogart Wealth LLC sold 82,616 Boston Scientific shares in Q1 2026, an estimated $6.61M.
  • Boston Scientific made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #680 holding.
  • Bogart Wealth LLC first reported a position in Boston Scientific in Q3 2022 and has held it in 14 quarters since.
  • Bogart Wealth LLC's Boston Scientific position peaked at $7.91M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.